OBJECTIVE: We have previously reported a limited but favorable experience with a novel
sutureless technique for surgical management of postoperative pulmonary vein stenosis …

The American Heart Association makes every effort to avoid any actual or potential conflicts
of interest that may arise as a result of an outside relationship or a personal, professional, or …

Interest for the pulmonary veins has increased in the past decade after the potential
arrhythmogenicity of the myocardial sleeve surrounding these structures has been …

The management of congenital heart disease has changed dramatically over the last 15
years and continues to evolve at a rapid pace. More than ever before contemporary practice …

Background—We sought to determine era-specific changes in the incidence of mortality and
reoperation in children with total anomalous pulmonary venous connection. Methods and …

Background: The occurrence of a progressive pulmonary venous obstruction after the repair
of the total anomalous pulmonary venous connection is a severe complication. Objectives …

Pulmonary vein stenosis (PVS) remains a formidable clinical challenge in congenital heart
disease. In recent years, the medical community has pushed to advance our understanding …

OBJECTIVES This study was performed to analyse the surgical results of total anomalous
pulmonary venous connection (TAPVC) repair at a single institution and to identify trends …

Objective To evaluate the use of imatinib mesylate with or without bevacizumab targeting
neoproliferative myofibroblast-like cells with tyrosine kinase receptor expression, as …

OBJECTIVE: Pulmonary venous obstruction (PVO) is an important cause of late mortality in
total anomalous pulmonary venous connection (TAPVC). We aimed to describe current …